Hyponatremia and seizures in young children given DDAVP.
about
Idiopathic intracranial hypertension and hemophilia A.Desmopressin in the treatment of women's bleeding disorders.Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyVon Willebrand factor and von Willebrand disease.Mild hemophilia A.The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents.Treatment of patients with von Willebrand disease.Advances in the diagnosis and management of von Willebrand disease.Principles of care for the diagnosis and treatment of von Willebrand disease.Management of inherited von Willebrand disease in 2007.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Evidence-based recommendations on the treatment of von Willebrand disease in Italy.The diagnosis and treatment of von Willebrand disease in children.Perioperative incidence and management of hyponatremia in vWD patients undergoing adenotonsillectomy.Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.von Willebrand disease and platelet disorders.Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A.Desmopressin use for minimising perioperative blood transfusion.Developmental hemostasis: laboratory and clinical implications.Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.An 11-year experience of acquired von Willebrand syndrome in children diagnosed with Wilms tumour in a tertiary referral centre.Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection.DDAVP challenge tests in boys with mild/moderate haemophilia A.Guidelines for the diagnosis and management of von Willebrand disease in Italy.Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease.Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).Guidelines for the management of hemophilia.Diagnosis and management of von Willebrand disease.Haemostatic treatment in connection with surgery in patients with von Willebrand disease.
P2860
Q30655575-5B199491-6876-493C-825B-172D8A303FAFQ33723752-836C3E7F-6421-4FAE-8EA1-1AD2F2BB9414Q33815766-E40ACD73-3B08-467F-8C44-A3BB0AE7372CQ34416394-E83F404B-1DB4-4AFC-BC6C-730D83DE56D1Q34530389-361B455F-F6FA-4070-AEA7-30B55B79D6C2Q34614695-29FFB886-BD7C-4BF5-AA7C-DCB72B0F9595Q34636885-8D3AE82C-4253-4B1B-9A19-0CF800FE07BDQ35683876-481B8FB6-D85A-4ECA-A800-72A35F3E914BQ36687984-D8C57501-DB38-4B84-AA8A-6183BDDAD65AQ36805813-4DD3969F-28A7-45DB-9E8E-F73CB041A384Q36911419-498C0A09-C269-4837-B0BF-D1A145EAA10BQ37100261-CF5EDE3B-2E43-4018-B50B-A1BD7EAA8177Q37209112-9A632EC4-8903-4026-ABA9-9F6616AC59E6Q37479585-F864C452-6FA2-49D4-A3CB-2D7DA41CF2F9Q37885851-43C6B09F-BD23-413E-B6FD-98AB6CB2E1DBQ38128397-1FFC428E-D24C-4432-B634-01947C27BC4EQ38206854-A943DC37-3881-4206-80F4-E7CFB47BB874Q38241445-D9C0C63E-0EEE-4045-A16A-350794CD6E67Q38687047-120A8867-9CF9-462B-91CC-6ED13F13BDC0Q38900007-27D324E3-511D-4055-8873-41080667CB0BQ38900471-472F2CED-5475-474D-8DB6-6FF9EAD136E2Q38951431-50AA4D86-C66D-49C5-9AEF-4FCEA064ED8AQ41850245-691A5DD2-941A-4187-9ED2-8060A2897FB9Q44024550-86C58E76-403C-4FD4-A006-9B43CF355C80Q44117199-0DE41CE1-111C-4DCB-BEBE-C4150DCF7C13Q45855997-364F5501-BF88-46A1-9788-7CE46B6D6E8AQ45869812-73AC0156-BDA8-40A7-A2C3-B494EC9F877EQ45870175-CB656259-4783-4CF1-87B1-BC5F4DB5F6A0Q45871911-26843470-941C-4001-9B35-5C6BDBBA8858Q45879438-87B4C77F-4DAD-4E3B-97A9-DE084A2F4A29Q45880345-22C31141-3331-4FDB-A1D0-096E7C88E0A4Q45884955-3276DBA4-8177-4503-A240-226061B4108BQ45884986-FAA42500-D9EF-4325-A431-ABE195470551
P2860
Hyponatremia and seizures in young children given DDAVP.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hyponatremia and seizures in young children given DDAVP.
@en
type
label
Hyponatremia and seizures in young children given DDAVP.
@en
prefLabel
Hyponatremia and seizures in young children given DDAVP.
@en
P2093
P356
P1476
Hyponatremia and seizures in young children given DDAVP.
@en
P2093
P2860
P304
P356
10.1002/AJH.2830310310
P577
1989-07-01T00:00:00Z